Review




Structured Review

Motic Group inverted bright field microscope
USP18 deficiency inhibits the growth of ccRCC organoids (A and <t>B)</t> <t>Bright-field</t> (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.
Inverted Bright Field Microscope, supplied by Motic Group, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pmc13157185-104-0-4?v=Motic+Group
Average 86 stars, based on 1 article reviews
inverted bright field microscope - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3"

Article Title: USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3

Journal: iScience

doi: 10.1016/j.isci.2026.115808

USP18 deficiency inhibits the growth of ccRCC organoids (A and B) Bright-field (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.
Figure Legend Snippet: USP18 deficiency inhibits the growth of ccRCC organoids (A and B) Bright-field (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.

Techniques Used: Expressing, Control, Transfection, ATP Assay, Western Blot, Two Tailed Test



Similar Products

86
Motic Group inverted bright field microscope
USP18 deficiency inhibits the growth of ccRCC organoids (A and <t>B)</t> <t>Bright-field</t> (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.
Inverted Bright Field Microscope, supplied by Motic Group, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pmc13157185-104-0-4?v=Motic+Group
Average 86 stars, based on 1 article reviews
inverted bright field microscope - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

99
Nikon bright field transmission microscope
USP18 deficiency inhibits the growth of ccRCC organoids (A and <t>B)</t> <t>Bright-field</t> (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.
Bright Field Transmission Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pm41922772-398-6-9?v=Nikon
Average 99 stars, based on 1 article reviews
bright field transmission microscope - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

97
Carl Zeiss bright field microscope
Fabrication and stability of biotin‐functionalized hybrid microgels loaded with MNPs. (A) Scheme illustrating droplet microfluidics‐assisted fabrication of biotin‐functionalized, poly(acrylamide)‐based hybrid microgels with MNPs. HµGel‐XB denotes biotinylated microgel, where X indicates biotin‐PEG‐acrylamide concentration in the precursor solution in % ( w/w ). Following ultrasonic treatment, the precursor solution is injected into microfluidic channels with flow‐focusing design (as shown in the AutoCAD design). Crosslinking of water‐in‐oil (W/O) emulsion droplets occurs via UV irradiation within the outflow tubing. (B) MNP stability in the precursor solution over time demonstrated <t>by</t> <t>bright‐field</t> microscopy images of purified microgels containing 1% ( w/w ) MNP and 2.5% biotin (HµGel‐2.5B) after 1.5 and 3.5 h of experimentation, respectively. Insets show uniform distribution of MNPs within the microgels and reveal consistent MNP loading during microfluidic processing over time. All scale bars denote 150 μm.
Bright Field Microscope, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pmc13039770-168-20-28?v=Carl+Zeiss
Average 97 stars, based on 1 article reviews
bright field microscope - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

97
Carl Zeiss primovert bright field microscope
Fabrication and stability of biotin‐functionalized hybrid microgels loaded with MNPs. (A) Scheme illustrating droplet microfluidics‐assisted fabrication of biotin‐functionalized, poly(acrylamide)‐based hybrid microgels with MNPs. HµGel‐XB denotes biotinylated microgel, where X indicates biotin‐PEG‐acrylamide concentration in the precursor solution in % ( w/w ). Following ultrasonic treatment, the precursor solution is injected into microfluidic channels with flow‐focusing design (as shown in the AutoCAD design). Crosslinking of water‐in‐oil (W/O) emulsion droplets occurs via UV irradiation within the outflow tubing. (B) MNP stability in the precursor solution over time demonstrated <t>by</t> <t>bright‐field</t> microscopy images of purified microgels containing 1% ( w/w ) MNP and 2.5% biotin (HµGel‐2.5B) after 1.5 and 3.5 h of experimentation, respectively. Insets show uniform distribution of MNPs within the microgels and reveal consistent MNP loading during microfluidic processing over time. All scale bars denote 150 μm.
Primovert Bright Field Microscope, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pm41894455-155-25-24?v=Carl+Zeiss
Average 97 stars, based on 1 article reviews
primovert bright field microscope - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

97
Carl Zeiss bright field inverted microscope
Workflow for intestinal organoid generation and monolayer preparation (A) Schematic representation of tissue processing, crypt isolation, and embedding in BME domes to establish 3D intestinal organoids. (B) Overview of organoid dissociation and seeding onto wells to generate organoid-derived monolayers (ODMs). (C) BME domes containing organoids; (D) <t>Bright</t> <t>field</t> image of organoids ready for ODM seeding; (E) Bright field image of organoids not suitable for ODM seeding. They have overgrown and there are too many dead cells in the lumen. Scale bar: 100 μm. Created with Biorender.com.
Bright Field Inverted Microscope, supplied by Carl Zeiss, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pmc12915229-95-0-12?v=Carl+Zeiss
Average 97 stars, based on 1 article reviews
bright field inverted microscope - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

99
Nikon bright field inverted microscope
Workflow for intestinal organoid generation and monolayer preparation (A) Schematic representation of tissue processing, crypt isolation, and embedding in BME domes to establish 3D intestinal organoids. (B) Overview of organoid dissociation and seeding onto wells to generate organoid-derived monolayers (ODMs). (C) BME domes containing organoids; (D) <t>Bright</t> <t>field</t> image of organoids ready for ODM seeding; (E) Bright field image of organoids not suitable for ODM seeding. They have overgrown and there are too many dead cells in the lumen. Scale bar: 100 μm. Created with Biorender.com.
Bright Field Inverted Microscope, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/10__1186_slash_s40691___026___00454___1-100-45-50?v=Nikon
Average 99 stars, based on 1 article reviews
bright field inverted microscope - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

98
Danaher Inc leica dmi1 bright field microscope
Workflow for intestinal organoid generation and monolayer preparation (A) Schematic representation of tissue processing, crypt isolation, and embedding in BME domes to establish 3D intestinal organoids. (B) Overview of organoid dissociation and seeding onto wells to generate organoid-derived monolayers (ODMs). (C) BME domes containing organoids; (D) <t>Bright</t> <t>field</t> image of organoids ready for ODM seeding; (E) Bright field image of organoids not suitable for ODM seeding. They have overgrown and there are too many dead cells in the lumen. Scale bar: 100 μm. Created with Biorender.com.
Leica Dmi1 Bright Field Microscope, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inverted+bright+field+microscope/pm41499484-292-36-40?v=Danaher+Inc
Average 98 stars, based on 1 article reviews
leica dmi1 bright field microscope - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier

Image Search Results


USP18 deficiency inhibits the growth of ccRCC organoids (A and B) Bright-field (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.

Journal: iScience

Article Title: USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3

doi: 10.1016/j.isci.2026.115808

Figure Lengend Snippet: USP18 deficiency inhibits the growth of ccRCC organoids (A and B) Bright-field (A, scale bars, 500 μm) and H&E (B, scale bars, 100 μm) images showing the morphology and structure of ccRCC organoids from three patient samples. (C and D) IF data show the expression of CK7 (C) and Vimentin (D) in ccRCC organoids (scale bars, 100 μm). (E) Bright-field images showing the morphology of control and USP18-deficient ccRCC organoids. “Before” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 72 h, and “after” indicates the bright-field image of the organoids after transfection with shNC/shUSP18 at 96 h. The images taken before and after are of the same organoids at different time points in the same field of view. (F) Change in diameter (%) of control and USP18-deficient ccRCC organoids. (G) ATP assay indicating the viability of control and USP18-deficient ccRCC organoids. (H and I) Western blot data indicate the expression of USP18, YBX3, P-AKT, and P-PI3K in control and USP18-deficient ccRCC organoids. Unpaired two-tailed Student’s t test was employed for p -value calculation. Data are represented as mean ± SD.

Article Snippet: Inverted bright-field microscope , Motic , N/A.

Techniques: Expressing, Control, Transfection, ATP Assay, Western Blot, Two Tailed Test

Fabrication and stability of biotin‐functionalized hybrid microgels loaded with MNPs. (A) Scheme illustrating droplet microfluidics‐assisted fabrication of biotin‐functionalized, poly(acrylamide)‐based hybrid microgels with MNPs. HµGel‐XB denotes biotinylated microgel, where X indicates biotin‐PEG‐acrylamide concentration in the precursor solution in % ( w/w ). Following ultrasonic treatment, the precursor solution is injected into microfluidic channels with flow‐focusing design (as shown in the AutoCAD design). Crosslinking of water‐in‐oil (W/O) emulsion droplets occurs via UV irradiation within the outflow tubing. (B) MNP stability in the precursor solution over time demonstrated by bright‐field microscopy images of purified microgels containing 1% ( w/w ) MNP and 2.5% biotin (HµGel‐2.5B) after 1.5 and 3.5 h of experimentation, respectively. Insets show uniform distribution of MNPs within the microgels and reveal consistent MNP loading during microfluidic processing over time. All scale bars denote 150 μm.

Journal: Chembiochem

Article Title: Droplet Microfluidics‐Assisted Fabrication of Magnetite Nanoparticle Hybrid Microgels for Facile Protein Immobilization

doi: 10.1002/cbic.202500958

Figure Lengend Snippet: Fabrication and stability of biotin‐functionalized hybrid microgels loaded with MNPs. (A) Scheme illustrating droplet microfluidics‐assisted fabrication of biotin‐functionalized, poly(acrylamide)‐based hybrid microgels with MNPs. HµGel‐XB denotes biotinylated microgel, where X indicates biotin‐PEG‐acrylamide concentration in the precursor solution in % ( w/w ). Following ultrasonic treatment, the precursor solution is injected into microfluidic channels with flow‐focusing design (as shown in the AutoCAD design). Crosslinking of water‐in‐oil (W/O) emulsion droplets occurs via UV irradiation within the outflow tubing. (B) MNP stability in the precursor solution over time demonstrated by bright‐field microscopy images of purified microgels containing 1% ( w/w ) MNP and 2.5% biotin (HµGel‐2.5B) after 1.5 and 3.5 h of experimentation, respectively. Insets show uniform distribution of MNPs within the microgels and reveal consistent MNP loading during microfluidic processing over time. All scale bars denote 150 μm.

Article Snippet: Droplet formation was monitored through a high‐speed camera (Miro C110, Vision Research Inc., Wayne, NJ, USA) coupled to an inverted bright‐field microscope (10× objective lens, air, Axio Vert.A1, Carl Zeiss, Oberkochen, Germany).

Techniques: Concentration Assay, Injection, Emulsion, Irradiation, Microscopy, Purification

Immobilization of sfGFP‐Mad10trunc‐His fusion protein on MNPs embedded inside pAAm‐based hybrid microgels. (A) 10× and (B) 40× bright‐field and corresponding CLSM microscopy images showing the selective binding of sfGFP‐Mad10trunc‐His to MNPs within HµGel‐1.25B after 3 days of incubation. All scale bars denote 150 µm.

Journal: Chembiochem

Article Title: Droplet Microfluidics‐Assisted Fabrication of Magnetite Nanoparticle Hybrid Microgels for Facile Protein Immobilization

doi: 10.1002/cbic.202500958

Figure Lengend Snippet: Immobilization of sfGFP‐Mad10trunc‐His fusion protein on MNPs embedded inside pAAm‐based hybrid microgels. (A) 10× and (B) 40× bright‐field and corresponding CLSM microscopy images showing the selective binding of sfGFP‐Mad10trunc‐His to MNPs within HµGel‐1.25B after 3 days of incubation. All scale bars denote 150 µm.

Article Snippet: Droplet formation was monitored through a high‐speed camera (Miro C110, Vision Research Inc., Wayne, NJ, USA) coupled to an inverted bright‐field microscope (10× objective lens, air, Axio Vert.A1, Carl Zeiss, Oberkochen, Germany).

Techniques: Microscopy, Binding Assay, Incubation

Workflow for intestinal organoid generation and monolayer preparation (A) Schematic representation of tissue processing, crypt isolation, and embedding in BME domes to establish 3D intestinal organoids. (B) Overview of organoid dissociation and seeding onto wells to generate organoid-derived monolayers (ODMs). (C) BME domes containing organoids; (D) Bright field image of organoids ready for ODM seeding; (E) Bright field image of organoids not suitable for ODM seeding. They have overgrown and there are too many dead cells in the lumen. Scale bar: 100 μm. Created with Biorender.com.

Journal: STAR Protocols

Article Title: Protocol to enhance pre-sexual and sexual differentiation of Toxoplasma gondii using retinal cells and intestinal organoid-derived monolayers

doi: 10.1016/j.xpro.2026.104367

Figure Lengend Snippet: Workflow for intestinal organoid generation and monolayer preparation (A) Schematic representation of tissue processing, crypt isolation, and embedding in BME domes to establish 3D intestinal organoids. (B) Overview of organoid dissociation and seeding onto wells to generate organoid-derived monolayers (ODMs). (C) BME domes containing organoids; (D) Bright field image of organoids ready for ODM seeding; (E) Bright field image of organoids not suitable for ODM seeding. They have overgrown and there are too many dead cells in the lumen. Scale bar: 100 μm. Created with Biorender.com.

Article Snippet: Bright-field inverted microscope (20× 0.3 NA and 40× 0.8 NA objectives) , Zeiss , Primovert.

Techniques: Isolation, Derivative Assay